PE Ratio
N/A
Wed, 27 Nov 2024 14:30:00 GMT
Summary:
COSCIENS Biopharma price to earnings ratio is not available.CSCI PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSCI PE Ratio Performance
| PeriodPeriod | PE ratioPE ratio | PricePrice | TTM EPSTTM EPS | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | - | +0.7% | -55.8% | -1.1% |
| 1 m1 month | - | -16.3% | - | - |
| 3 m3 months | - | -22.0% | - | - |
| 6 m6 months | - | -63.1% | - | - |
| ytdytd | - | -58.5% | - | - |
| 1 y1 year | - | -64.7% | -287.8% | -10.3% |
| 5 y5 years | - | -96.6% | -725.1% | -23.4% |
CSCI PE Ratio High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | ||||
| 3 m | 3 months | ||||
| 6 m | 6 months | ||||
| 1 y | 1 year | ||||
| 3 y | 3 years | 67.63 | 7.22 | ||
| 5 y | 5 years | 832.92 | 7.22 | ||
| alltime | all time | 22.03 M | 7.22 |
COSCIENS Biopharma PE Ratio History
| Date | Value |
|---|---|
| 2022 | 7.66(-71.4%) |
| 2021 | 26.82(-75.0%) |
| 2020 | 107.23(-52.5%) |
| 2016 | 225.71(+35.0%) |
| 2015 | 167.23(-96.6%) |
| 2014 | 4896.76(-85.2%) |
| Date | Value |
|---|---|
| 2013 | 33.13 K(-84.1%) |
| 2011 | 208.72 K(-97.4%) |
| 2010 | 7.94 M(-24.0%) |
| 2005 | 10.44 M(+2079.4%) |
| 2003 | 479.21 K(-76.0%) |
| 2002 | 2.00 M |
FAQ
- What is the all time high PE ratio for COSCIENS Biopharma?
What is the all time high PE ratio for COSCIENS Biopharma?
COSCIENS Biopharma all-time high price to earnings ratio is 22.03 M